Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DEXRAZOXANE, with a corresponding US DMF Number 37716.
Remarkably, this DMF maintains an Active status since its submission on November 22, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 12, 2022, and payment made on November 22, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II